Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer

NCT04724031 · clinicaltrials.gov ↗

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: PARP inhibitor

Sponsor

Hellenic Cooperative Oncology Group